Nuvation Bio Inc
(NUVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NUVB | RARE | SRPT | ||
| Company | Nuvation Bio Inc | Ultragenyx Pharmaceu | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 5.85 | 21.54 | 17.56 | ||
| High | 6.05 | 23.17 | 18.19 | ||
| Low | 5.71 | 19.60 | 17.50 | ||
| Latest | 5.77 | 20.52 | 17.79 | ||
| Change | -0.02 | -2.98 | +0.39 | ||
| % Change | -0.35% | -12.68% | +2.24% | ||
| Volume | 2,506,500 | 7,200,500 | 1,554,900 | ||
| 20-Day Average Volume | 5,424,735 | 2,486,595 | 2,717,280 | ||
| Previous Close | 5.79 | 23.50 | 17.40 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.69 | 23.80 | 20.02 | ||
| 20-Day Raw Stochastic | 57.52% | 14.72% | 11.50% | ||
| 20-Day Relative Strength | 41.70 | 33.75 | 40.69 | ||
| Weighted Alpha | +102.89 | -43.00 | -57.55 | ||
| Today's Opinion | 24% Buy | 100% Sell | 72% Sell | ||
| Previous Opinion | 24% Buy | 100% Sell | 72% Sell | ||
| Last Month's Opinion | 56% Buy | 96% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.23% since 02/06/26 | -16.92% since 02/06/26 | -3.84% since 02/06/26 | ||
| Low | 5.31 on 02/09/26 | 19.60 on 02/13/26 | 17.24 on 02/12/26 | ||
| High | 6.05 on 02/13/26 | 24.68 on 02/10/26 | 18.69 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | -11.91% since 01/13/26 | -14.89% since 01/13/26 | -17.10% since 01/13/26 | ||
| Low | 5.12 on 01/30/26 | 19.60 on 02/13/26 | 16.90 on 02/05/26 | ||
| High | 6.63 on 01/14/26 | 25.82 on 02/03/26 | 24.68 on 01/26/26 | ||
| 3-Month | |||||
| %Chg | +23.03% since 11/13/25 | -37.63% since 11/13/25 | -0.17% since 11/13/25 | ||
| Low | 4.53 on 11/14/25 | 18.41 on 12/29/25 | 15.94 on 11/19/25 | ||
| High | 9.75 on 12/22/25 | 39.89 on 12/08/25 | 24.68 on 01/26/26 | ||
| 6-Month | |||||
| %Chg | +121.07% since 08/13/25 | -29.17% since 08/13/25 | -12.79% since 08/13/25 | ||
| Low | 2.57 on 08/20/25 | 18.41 on 12/29/25 | 15.08 on 11/04/25 | ||
| High | 9.75 on 12/22/25 | 39.89 on 12/08/25 | 25.32 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,978,146 | 1,979,729 | 1,864,161 | ||
| Shares Outstanding, K | 342,833 | 96,478 | 104,787 | ||
| Annual Sales | 7,870,000 | 560,230,000 | 1,901,980,000 | ||
| Annual Net Income | -567,940,000 | -569,180,000 | 235,240,000 | ||
| Last Quarter Sales | 13,120,000 | 159,930,000 | 399,360,000 | ||
| Last Quarter Net Income | -55,790,000 | -180,410,000 | -179,950,000 | ||
| 60-Month Beta | 1.51 | 0.16 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 11/03/25 | -1.29 on 02/12/26 | -0.13 on 11/03/25 | ||
| Latest Earnings Date | 03/05/26 | 05/05/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||